© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Elagolix Sodium falls under a class of synthetic, non-peptide, orally active GnRH (gonadotropin-releasing hormone) antagonists. Its main use centers around the treatment of hormone-related disorders, such as endometriosis and uterine fibroids, by reducing the production of certain hormones that cause symptoms linked to these conditions. The chemical structure supports a fast onset of action, which allows accurate dose adjustments in real clinical settings. Its role as a raw material in pharmaceutical applications depends heavily on both physical and chemical purity, so supply chain oversight matters for quality assurance.
This compound appears as a fine, off-white to yellowish powder. Its crystalline structure helps with storage stability and influences how it dissolves in common solvents. Labs and manufacturing teams work with this solid form because it reduces the risk of moisture absorption, which protects the core molecule from breakdown over time. Some batches might arrive as flakes or in a denser powder state, which depends on the granulation process and storage conditions. The formula for Elagolix Sodium reads C32H30F5N3Na2O5S, which tells you a lot about its weight and solubility patterns.
A molecular weight of around 727.64 g/mol gives it heft, making it important to precisely measure and handle during compounding. Density ranges from about 1.3 to 1.6 g/cm³, a spec that helps technicians estimate how much to pour or scoop for solutions or suspensions. Teams who prepare research solutions often achieve a uniform mix at room temperature by stirring carefully, since the compound does not dissolve easily in water but does fare well in polar organic solvents. Safe handling calls for a dry, cool, and well-ventilated working space, away from direct sunlight. Gloves and eye protection cut down exposure risks.
Looking closer at the structure, Elagolix Sodium features a combination of aromatic and aliphatic rings, as well as functional groups like sulfonamides and trifluoromethylphenyl units, which influence both its biological activity and stability. A three-dimensional lattice of sodium ions balances the molecule’s charge, providing better shelf-life and reducing risk of degradation during transport or long-term storage. Analytical labs use IR, NMR, and mass spectrometry to confirm the integrity of each batch, as these measures flag unwanted impurities that might raise regulatory issues or cause processing hiccups. Specifications typically call for purity above 99%, with extremely low water and residual solvent content.
Product batches listed for international trade use the HS Code 2934999099, which places Elagolix Sodium in the “other heterocyclic compounds” category. Customs and suppliers reference this code when moving the product across borders, reducing confusion and paperwork during import or export. Shipment paperwork usually carries a Material Safety Data Sheet (MSDS) outlining properties such as melting point, which often lands in the 200–220°C range, as well as thermal stability and incompatibility data. Direct skin or eye contact brings mild to moderate irritation risks, so facility managers require chemical-resistant gloves, dedicated fume hoods, and emergency eyewash stations close to work areas. Those handling large-scale operations keep powder collection systems in place to reduce accidental inhalation or dispersion of the fine crystals.
Lab techs encounter Elagolix Sodium primarily as a dry powder or fine crystalline flakes. Its free-flowing nature simplifies weight measurement, though some lots may compact under pressure, requiring gentle agitation before use. Production professionals prefer this raw material state since the absence of liquid carriers, beads, pearls, or solutions means less risk of spoilage during international shipping. In rare cases, researchers formulate it into liquid solutions with DMSO or ethanol for in vitro studies, carefully noting stability and shelf-life. Stability studies show the product retains its properties best at stable room temperature in airtight containers, far from volatile acids or bases that would trigger unwanted reactions.
Elagolix Sodium rates as a low-to-moderate chemical hazard under established GHS classification. It doesn't carry high flammability or explosiveness risks, but it does present concerns for users prone to chemical sensitivities, so proper risk assessment guides all phases of handling. Accidental contact with eyes or skin brings localized irritation, prompting facility supervisors to post clear signage about personal protective equipment requirements. Chemical hygiene plans mandate basic housekeeping: sealed storage, spill cleanup materials, and up-to-date training on emergency response. Those with long-term exposure—like workers at active pharmaceutical ingredient (API) plants—undergo routine health monitoring and medical checkups to catch any early signs of sensitivity.
Companies use Elagolix Sodium as a bulk raw material in high-value drug formulations, so strict testing protocols govern its entry into production suites. Counterfeiting and inconsistent material quality in some regions introduce unnecessary costs and safety risks, which shines a spotlight on trusted suppliers and robust chain-of-custody records. Many pharma facilities invest in local analytical chemistry labs for in-house verification, reducing shipping delays while catching out-of-spec lots before they enter sensitive processes. These proactive moves support compliance with agencies such as the FDA or EMA, which draw on E-E-A-T principles—experience, expertise, authoritativeness, and trustworthiness—to keep products on the market safe.
The rise of sustainable chemistry adds another wrinkle, as more manufacturers seek raw materials that support greener processing. Teams increasingly look for information about solvent recovery, closed-loop handling systems, and reduced packaging waste. By opening data about batch characteristics, storage temperatures, and risk factors, suppliers help their clients avoid surprises, protect workers, and meet demand for high-quality therapeutics. For anyone who’s ever walked into a busy API production room, watched a kilo of powder turn into a finished capsule, and seen the impact on patient outcomes, these quality and safety measures feel personal, not just regulatory.
Elagolix Sodium brings a blend of dense molecular weight, well-defined physical properties, and precise chemical structure, which shoestrings research with industrial production. Its powder or flake forms offer versatility, and its crystalline matrix keeps it stable during storage and shipping. Handling teams keep a close eye on density specs and storage conditions, making sure material flows smoothly from drum to lab to line. Suitably stored, it retains stability and potency, supporting the intricate dance between chemistry, safety protocols, and health outcomes.
